Published in AIDS Res Hum Retroviruses on March 17, 2016
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med (1998) 5.08
Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS (Auckl) (2015) 1.61
Association between antiretrovirals and thyroid diseases: a cross-sectional study. Arch Endocrinol Metab (2015) 1.26
Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. AIDS Res Hum Retroviruses (1999) 1.13
Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) (2005) 1.11
Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy. Lancet (1998) 1.02
Autoimmune diseases in HIV-infected patients: 52 cases and literature review. Autoimmun Rev (2014) 1.00
Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS (2006) 0.95
Graves' Disease as a Manifestation of Immune Reconstitution in HIV-Infected Individuals after Initiation of Highly Active Antiretroviral Therapy. AIDS Res Treat (2011) 0.83
Prevalence and Predictors of Thyroid Dysfunction in Patients with HIV Infection and Acquired Immunodeficiency Syndrome: An Indian Perspective. J Thyroid Res (2015) 0.83
Graves' disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4(+) T-cell recovery. AIDS (2014) 0.83
Prevalence of thyroid dysfunction and its correlation with CD4 count in newly-diagnosed HIV-positive adults - a cross-sectional study. Int J STD AIDS (2014) 0.82
The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection. AIDS Rev (2015) 0.81
Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy. J Clin Endocrinol Metab (2015) 0.79